482 related articles for article (PubMed ID: 16552235)
1. Radiotherapy for head and neck cancer: latest developments and future perspectives.
Bernier J; Bentzen SM
Curr Opin Oncol; 2006 May; 18(3):240-6. PubMed ID: 16552235
[TBL] [Abstract][Full Text] [Related]
2. Alteration of radiotherapy fractionation and concurrent chemotherapy: a new frontier in head and neck oncology?
Bernier J
Nat Clin Pract Oncol; 2005 Jun; 2(6):305-14. PubMed ID: 16264988
[TBL] [Abstract][Full Text] [Related]
3. Evidence-based radiation oncology in head and neck squamous cell carcinoma.
Corvò R
Radiother Oncol; 2007 Oct; 85(1):156-70. PubMed ID: 17482300
[TBL] [Abstract][Full Text] [Related]
4. Recent advances in radiotherapy for head and neck cancers.
Chou RH; Wilder RB; Wong MS; Forster KM
Ear Nose Throat J; 2001 Oct; 80(10):704-7, 711-4, 716 passim. PubMed ID: 11605568
[TBL] [Abstract][Full Text] [Related]
5. Head and neck squamous cell carcinoma: optimizing the therapeutic index.
Rosenthal DI; Blanco AI
Expert Rev Anticancer Ther; 2005 Jun; 5(3):501-14. PubMed ID: 16001957
[TBL] [Abstract][Full Text] [Related]
6. Challenges of integrating chemotherapy and targeted therapy with radiation in locally advanced head and neck squamous cell cancer.
Marur S; Forastiere AA
Curr Opin Oncol; 2010 May; 22(3):206-11. PubMed ID: 20216313
[TBL] [Abstract][Full Text] [Related]
7. New perspectives in medical approach to therapy of head and neck squamous cell carcinoma.
Santarelli A; Lo Russo L; Bambini F; Campisi G; Lo Muzio L
Minerva Stomatol; 2009 Sep; 58(9):445-52. PubMed ID: 19893469
[TBL] [Abstract][Full Text] [Related]
8. Comparison of hyperfractionation and conventional fractionation radiotherapy with concurrent docetaxel, cisplatin and 5-fluorouracil (TPF) chemotherapy in patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN).
Katori H; Tsukuda M; Watai K
Cancer Chemother Pharmacol; 2007 Aug; 60(3):399-406. PubMed ID: 17096160
[TBL] [Abstract][Full Text] [Related]
9. Concurrent chemotherapy and radiotherapy for head and neck cancer.
Burri RJ; Lee NY
Expert Rev Anticancer Ther; 2009 Mar; 9(3):293-302. PubMed ID: 19275508
[TBL] [Abstract][Full Text] [Related]
10. Altered-fractionated radiotherapy in locally advanced head and neck cancer.
Bernier J; Horiot JC
Curr Opin Oncol; 2012 May; 24(3):223-8. PubMed ID: 22123237
[TBL] [Abstract][Full Text] [Related]
11. Altered radiation therapy fractionation, chemoradiation, and patient selection for the treatment of head and neck squamous carcinoma.
Rosenthal DI; Ang KK
Semin Radiat Oncol; 2004 Apr; 14(2):153-66. PubMed ID: 15095261
[TBL] [Abstract][Full Text] [Related]
12. Intensity-modulated radiation therapy in advanced head and neck patients treated with intensive chemoradiotherapy: preliminary experience and future directions.
Milano MT; Vokes EE; Kao J; Jackson W; List MA; Stenson KM; Witt ME; Dekker A; MacCracken E; Garofalo MC; Chmura SJ; Weichselbaum RR; Haraf DJ
Int J Oncol; 2006 May; 28(5):1141-51. PubMed ID: 16596230
[TBL] [Abstract][Full Text] [Related]
13. Radiobiological modelling of the therapeutic ratio for the addition of synchronous chemotherapy to radiotherapy in locally advanced squamous cell carcinoma of the head and neck.
Hartley A; Sanghera P; Glaholm J; Mehanna H; McConkey C; Fowler J
Clin Oncol (R Coll Radiol); 2010 Mar; 22(2):125-30. PubMed ID: 19880297
[TBL] [Abstract][Full Text] [Related]
14. Current state-of-the-art for concurrent chemoradiation.
Bernier J
Semin Radiat Oncol; 2009 Jan; 19(1):3-10. PubMed ID: 19028339
[TBL] [Abstract][Full Text] [Related]
15. Radiation treatment interruptions greater than one week and low hemoglobin levels (12 g/dL) are predictors of local regional failure after definitive concurrent chemotherapy and intensity-modulated radiation therapy for squamous cell carcinoma of the head and neck.
McCloskey SA; Jaggernauth W; Rigual NR; Hicks WL; Popat SR; Sullivan M; Mashtare TL; Khan MK; Loree TR; Singh AK
Am J Clin Oncol; 2009 Dec; 32(6):587-91. PubMed ID: 19581794
[TBL] [Abstract][Full Text] [Related]
16. Analysis of efficacy and toxicity of chemotherapy with cisplatin, 5-fluorouracil, methotrexate and leucovorin (PFML) and radiotherapy in the treatment of locally advanced squamous cell carcinoma of the head and neck.
Katori H; Tsukuda M; Taguchi T
Cancer Chemother Pharmacol; 2007 May; 59(6):789-94. PubMed ID: 17053926
[TBL] [Abstract][Full Text] [Related]
17. Chemoradiation therapy using radiotherapy, systemic chemotherapy with 5-fluorouracil and nedaplatin, and intra-arterial infusion using carboplatin for locally advanced head and neck cancer - Phase II study.
Fuwa N; Kodaira T; Furutani K; Tachibana H; Nakamura T; Daimon T
Oral Oncol; 2007 Nov; 43(10):1014-20. PubMed ID: 17258494
[TBL] [Abstract][Full Text] [Related]
18. [Recent developments in radiation oncology-integrating radiation physics and molecular radiobiology advances into clinical radiotherapy practice and beyond].
Teh BS; Paulino A; Butler EB
Ai Zheng; 2008 Aug; 27(8):885-93. PubMed ID: 18710628
[TBL] [Abstract][Full Text] [Related]
19. Radiotherapeutic management of locally advanced head and neck cancer.
Laskar SG; Agarwal JP; Srinivas C; Dinshaw KA
Expert Rev Anticancer Ther; 2006 Mar; 6(3):405-17. PubMed ID: 16503857
[TBL] [Abstract][Full Text] [Related]
20. Salivary gland carcinomas, paranasal sinus cancers and melanoma of the head and neck: an update about rare but challenging tumors.
Lalami Y; Vereecken P; Dequanter D; Lothaire P; Awada A
Curr Opin Oncol; 2006 May; 18(3):258-65. PubMed ID: 16552238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
